We facilitate access to stem cell treatments for autism, autism spectrum disorders (ASD), and other developmental disorders, connecting patients and their families with the most advanced specialized clinics.
Furthermore, this approach supports the integration of cutting-edge medical solutions, improving the quality of life for people with ASD and developmental disorders.
It also assists their families, helping them benefit from these innovative treatments.
The group of affiliated doctors evaluates patients’ medical files and assigns them to the appropriate clinics.
However, patients must provide essential details, including diagnosis, medical history, psychological assessment, ATEC report, and other investigations.
Therefore, the clinics offer personalized treatment solutions, from pro bono options to partially insured or private services, adapted to each country.
We are here to help you quickly and efficiently!
To check your eligibility, we invite you to take the first step and complete the form below.
Stem cell therapy offers a promising approach for treating inflammation and neuroinflammatory disorders, especially in children and adults with ASD. Moreover, intravenous and intrathecal administration of stem cells plays a key role in modulating neuroinflammatory processes. Scientific research supports this innovative autism treatment, showing potential benefits in reducing inflammation and promoting neural health.
Stem cells, especially mesenchymal stem cells (MSCs), play a key role in immunomodulation. Through their paracrine effects, MSCs positively influence inflammatory reactions and also regulate the immune response. They achieve this by releasing cytokines, growth factors, and exosomes, which affect inflammatory cells while supporting tissue regeneration.
Cytokine production and immunomodulation: MSCs interact with immune system cells, including macrophages, T cells, and dendritic cells, thereby regulating inflammatory processes. Importantly, this immune modulation is relevant in neuroinflammatory diseases, where the immune system can cross the blood-brain barrier and trigger neurodegenerative processes.
Reduction of inflammation: MSCs reduce pro-inflammatory cytokines, such as TNF-alpha, IL-6, and IL-1 beta, while simultaneously stimulating anti-inflammatory cytokines, such as IL-10 and TGF-beta. As a result, inflammation in affected tissues, including the central nervous system, is directly suppressed.
Stem cells, especially MSCs, may have a therapeutic role due to their anti-inflammatory properties and their ability to modulate microglial activity.
Supporting nerve regeneration: MSCs stimulate the regeneration of neurons and synaptic connections, therefore potentially reducing nerve tissue damage in neuroinflammatory disorders. Moreover, this effect improves neural function and can complement other therapeutic approaches.
Intravenous (IV) administration of stem cells is one of the most common methods because it enables a systemic effect. With this approach, stem cells quickly enter the bloodstream and reach various tissues, including the central nervous system. This route is particularly useful for peripheral inflammation or systemic neuroinflammatory diseases.
Distribution in the body: After intravenous injection, stem cells reach multiple target organs, including the brain and spinal cord. There, they modulate inflammation through paracrine effects while supporting tissue regeneration.
Advantages: Intravenous stem cell therapy is relatively simple and non-invasive. Moreover, the cells can reach areas of the body that are otherwise difficult to access.
Intrathecal (IT) administration involves direct injection of stem cells into the cerebrospinal fluid. This targeted method treats inflammation and neuroinflammatory conditions of the central nervous system. It is typically used when a rapid and localized effect on the brain or spinal cord is required.
Direct effect on the central nervous system: Injecting stem cells into the cerebrospinal fluid allows them to quickly reach the CNS and interact directly with inflammatory processes.
Targeted immunomodulation: Intrathecal administration provides a faster and more intense effect on inflammation because the cells contact local inflammatory cells directly.
Long-term use of this therapy has shown it to be safe and effective.
In addition, precise determination of the dose and cell source is essential for both intravenous and intrathecal administration to achieve optimal results.
Furthermore, stem cell therapy for autism, autism spectrum disorder (ASD), or other developmental disorders, especially when combined with brain stimulation, offers high therapeutic potential.
Consequently, this approach can positively influence condition progression while also improving the overall quality of life.
It is performed using STEM cells harvested from the patient’s own body. Specifically, bone marrow is usually collected by puncture from the iliac bone. Afterwards, the STEM cell concentrate is reinjected to stimulate tissue regeneration or to treat various conditions. Importantly, there is no risk of rejection or side effects.
It uses mesenchymal STEM cells taken from the blood vessels present in the umbilical cord of donors before the appearance of antibodies, therefore being universally compatible.
Moreover, these cells have anti-inflammatory and regenerative properties, and consequently are used to treat genetic, autoimmune, orthopedic, or degenerative diseases.
Discover the unique benefits of STEM Cell Treatment for the health of your little ones. Please complete the form below carefully, making sure to fill out all required fields.
If you have any difficulties completing the form or are experiencing technical issues, please send us all the necessary information to the email address below. We suggest using a data transfer platform
(e.g. WeTransfer, Google Drive) if the file size is too large.
Our team is at your disposal to provide fast and efficient support.